News
Minutes from the Annual General Meeting of Bionor Pharma ASA
Oslo 11.05.2012 - Bionor Pharma ASA's Annual General Meeting was held today. All proposed resolutions in the notice to the meeting were approved by the shareholders.
Read more about Minutes from the Annual General Meeting of Bionor Pharma ASANew Board after Annual General Meeting
Oslo 11.05.2012 - Bionor Pharma`s Shareholders Voted Industry Experts Steen Krøyer, Jerry Zeldis and Benedicte Fossum to its Board of Directors at Annual General Meeting
Read more about New Board after Annual General MeetingNytt styre etter årets generalforsamling
Oslo 11.05.2012 - Bionor Pharmas aksjonærer stemte for industriekspertene Steen Krøyer, Jerry Zeldis og Benedicte Fossum til styret ved den årlige generalforsamlingen
Read more about Nytt styre etter årets generalforsamlingNominations for Annual General Meeting of Bionor Pharma ASA 11 May 2012
Oslo 04.05.2012 - Bionor Pharma ASA announced today the Nomination Committee`s recommended candidates for the Board of Directors and the Nomination Committee at the Company`s Ordinary General Meeting 11 May.
Read more about Nominations for Annual General Meeting of Bionor Pharma ASA 11 May 2012Nomineringer til Generalforsamlingen i Bionor Pharma ASA 11. mai 2012
Oslo 04.05.2012 - Bionor Pharma ASA offentliggjorde i dag valgkomitéens nominasjoner for valg av nytt styre og valgkomité på selskapets ordinære generalforsamling 11. mai 2012.
Read more about Nomineringer til Generalforsamlingen i Bionor Pharma ASA 11. mai 2012Meldepliktig handel
Oslo, 27. april 2012 Marianne Furru, styremedlem i Bionor Pharma ASA har i dag kjøpt 100.000 aksjer
Read more about Meldepliktig handelMandatory notification of Trade
(Oslo, 27 April 2012) Marianne Furru, Board member of Bionor Pharma ASA, has today purchased 100,000 shares
Read more about Mandatory notification of TradeInvitation to Annual General Meeting 11 May 2012
Oslo, 20 April 2012 - The Annual General Meeting of Bionor Pharma ASA will be held on Friday 11 May 2012, 10:00 a.m. at Kronprinsesse Marthas Plass 1, Oslo
Read more about Invitation to Annual General Meeting 11 May 2012Innkalling til ordinær generalforsamling i Bionor Pharma ASA 11.05.2012
Oslo, 20.04.2012 - Den ordinære generalforsamlingen i Bionor Pharma ASA vil bli avholdt fredag 11. mai 2012 klokken 10.00 i Kronprinsesse Märthas plass 1, 2. etg., Oslo.
Read more about Innkalling til ordinær generalforsamling i Bionor Pharma ASA 11.05.2012Bionor Pharma Nominates Celgene`s Jerome Zeldis, MD, PhD, to Board of Directors
Oslo 11.04.2012 - Bionor Pharma (OSE: BIONOR) today announced thatJerome ("Jerry") Zeldis, MD, PhD, has been nominated by the Company's ElectionCommittee to its Board of Directors.
Read more about Bionor Pharma Nominates Celgene`s Jerome Zeldis, MD, PhD, to Board of DirectorsBionor Pharma nominerer Celgenes Jerome Zeldis, MD, PhD, til styret
Oslo 11.04 2012 - Bionor Pharma kunngjorde i dag at Jerome("Jerry") Zeldis, MD, PhD, har blitt nominert som nytt styremedlem av selskapetsvalgkomité.
Read more about Bionor Pharma nominerer Celgenes Jerome Zeldis, MD, PhD, til styretMandatory notification of trade
Oslo 06.03.2012 - Consultant for Bionor Pharma ASA, David Sheon, has yesterday purchased 7,500 Bionor shares at an average of NOK 2.93 per share.
Read more about Mandatory notification of tradeMandatory notification of trade
Oslo, 29.02.212 - CEO of Bionor Pharma ASA, Steen Krøyer, has today purchased 50,000 Bionor shares at an average of NOK 2.75 per share.
Read more about Mandatory notification of tradeFOURTH QUARTER AND FULL-YEAR RESULTS 2011
Oslo, 17.02.12 - Bionor Pharma ASA (OSE: BIONOR) today announced financial results for fourth quarter and full year 2011 and provided highlights of the key developments during the fourth quarter, current status and outlook.
Read more about FOURTH QUARTER AND FULL-YEAR RESULTS 2011Financial calendar 2012 for Bionor Pharma ASA
Read more about Financial calendar 2012 for Bionor Pharma ASABionor Pharma Strengthens International Team to Expedite Development and Commercialization of its Vaccines
Oslo 11.01.2012 - Bionor Pharma ASA today announcedhiring David Sheon, President at WHITECOAT Strategies, Washington DC, USA, on aconsultancy basis to further strengthen the management team throughinternational representation. David has over 20 years of experience consultingto biotechnology and pharmaceutical companies worldwide.
Read more about Bionor Pharma Strengthens International Team to Expedite Development and Commercialization of its VaccinesBionor Pharmas studie av HIV-vaksine med nasal administrasjon - alle pasienter er fullt innrullert
Oslo 04.01.2012 - Bionor Pharma studerer «nasal administrasjon» (nesedråper) av selskapets terapeutiske HIV vaksine Vacc-4x i kombinasjon med Eurocine Vaccine’s Endocine™. Alle pasienter er nå innrullert. En ny alternativ behandlingsform vil kunne gi lettere tilgang til behandling for HIV-positive globalt.
Read more about Bionor Pharmas studie av HIV-vaksine med nasal administrasjon - alle pasienter er fullt innrullertResearchers Study Nasal Administration of Bionor Pharma’s Therapeutic HIV Vaccine in Fully Enrolled Trial
Oslo 04.01.2012 - Researchers Study Nasal Administration of Bionor Pharma’s Therapeutic HIV Vaccine Vacc-4x Combined with Eurocine Vaccines’ Endocine™ in Fully Enrolled Trial; New Treatment Option Would Offer Easier Treatment Access for HIV Patients Globally.
Read more about Researchers Study Nasal Administration of Bionor Pharma’s Therapeutic HIV Vaccine in Fully Enrolled Trial